Phase II study of peptide vaccination for patients with metastatic lung or gastro-intestinal tract cancers

ABSTRACT: Interventions: peptide vaccinnation Primary outcome(s): Evaluation of efficacy by RECIST criteria Study Design: Single arm Non-randomized

DISEASE(S): Lung Cancer, Pharyngeal Cancer, Gastric Cancer, Jejunal Cancer, Ileal Cancer, Pancreas Cancer, Biliary Tract Cancer, Soft Tissue Sarcoma

PROVIDER: 2618328 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR